home / stock / anix / anix quote
Last: | $3.22 |
---|---|
Change Percent: | -1.86% |
Open: | $3.28 |
Close: | $3.22 |
High: | $3.44 |
Low: | $3.15 |
Volume: | 114,659 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.22 | $3.28 | $3.22 | $3.44 | $3.15 | 114,659 | 07-16-2024 |
$3.22 | $2.85 | $3.22 | $3.24 | $2.85 | 235,784 | 07-15-2024 |
$2.77 | $2.52 | $2.77 | $2.83 | $2.5 | 109,357 | 07-12-2024 |
$2.51 | $2.38 | $2.51 | $2.67 | $2.38 | 131,502 | 07-11-2024 |
$2.35 | $2.22 | $2.35 | $2.375 | $2.22 | 52,335 | 07-10-2024 |
$2.21 | $2.26 | $2.21 | $2.34 | $2.21 | 51,806 | 07-09-2024 |
$2.27 | $2.28 | $2.27 | $2.3344 | $2.21 | 60,384 | 07-08-2024 |
$2.29 | $2.28 | $2.29 | $2.326 | $2.2414 | 35,192 | 07-05-2024 |
$2.27 | $2.27 | $2.27 | $2.305 | $2.26 | 12,534 | 07-04-2024 |
$2.27 | $2.27 | $2.27 | $2.305 | $2.26 | 12,534 | 07-03-2024 |
$2.27 | $2.22 | $2.27 | $2.3099 | $2.16 | 34,049 | 07-02-2024 |
$2.22 | $2.2 | $2.22 | $2.28 | $2.2 | 32,436 | 07-01-2024 |
$2.21 | $2.28 | $2.21 | $2.34 | $2.145 | 138,364 | 06-28-2024 |
$2.38 | $2.35 | $2.38 | $2.43 | $2.35 | 35,646 | 06-27-2024 |
$2.37 | $2.48 | $2.37 | $2.5 | $2.37 | 36,377 | 06-26-2024 |
$2.47 | $2.52 | $2.47 | $2.61 | $2.47 | 34,827 | 06-25-2024 |
$2.5 | $2.5 | $2.5 | $2.55 | $2.4701 | 50,974 | 06-24-2024 |
$2.52 | $2.47 | $2.52 | $2.56 | $2.47 | 45,409 | 06-21-2024 |
$2.47 | $2.45 | $2.47 | $2.48 | $2.4001 | 53,684 | 06-20-2024 |
$2.47 | $2.57 | $2.47 | $2.5999 | $2.34 | 75,701 | 06-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Anixa Biosciences Inc. Company Name:
ANIX Stock Symbol:
NASDAQ Market:
Anixa Biosciences Inc. Website:
Anixa Biosciences Announces $5 Million Share Repurchase Program PR Newswire SAN JOSE, Calif. , July 15, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ...
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial PR Newswire This patient is expected to be the final patient in the second dosage cohort of the trial SAN JOSE, Calif. , June 24, 2024 /PRNewswire/ -- Anixa Biosciences, I...
2024-06-10 07:30:03 ET H.C. Wainwright analyst issues BUY recommendation for ANIX on June 10, 2024 06:07AM ET. The previous analyst recommendation was Buy. ANIX was trading at $2.55 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...